Skip to content
2000
Volume 6, Issue 7
  • ISSN: 1389-5575
  • E-ISSN: 1875-5607

Abstract

Myostatin is a negative regulator of muscle mass. Important advances in our understanding of thecomplex biology of this factor have revealed the therapeutic potential of antagonizing the myostatin pathway. Herewe present the rationale for evaluating anti-myostatin therapies in human muscle-wasting disorders.

Loading

Article metrics loading...

/content/journals/mrmc/10.2174/138955706777698642
2006-07-01
2025-06-23
Loading full text...

Full text loading...

/content/journals/mrmc/10.2174/138955706777698642
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test